Systematic review / meta-analysis / 2019
Vitamin D supplementation significantly reduced cancer mortality by 13% but did not significantly affect cancer incidence in a meta-analysis of 10 RCTs.
A meta-analysis of 10 randomized controlled trials with 81,362 participants evaluated the effect of vitamin D supplementation on cancer incidence and mortality. Cancer incidence was 9.16% in the vitamin D group versus 9.29% in the placebo group, showing no significant difference (RR 0.99, 95% CI: 0.94-1.03, P=0.532). Cancer mortality was significantly lower with vitamin D (2.11% vs. 2.43%; RR 0.87, 95% CI: 0.79-0.95, P=0.003). Subgroup analyses indicated that a history of cancer, extra vitamin D use, and calcium supplementation were potential sources of heterogeneity.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 81,362 participants across 10 randomized controlled trials
- What was measured
- Cancer incidence and cancer mortality
THE PAPER
Meta-analysis of randomized controlled trials on vitamin D supplement and cancer incidence and mortality.
Zhang X, Niu W. Biosci Rep, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.